Device Trial Radar · NCT02964000
Phoenix Thera-Lase for Treating Chronic Pain in Patients Taking Opioid on a PRN Basis
Last checked: Nov 20, 2026Latest source record: Feb 23, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
75
Planned (sponsor's estimate)
Start
Nov 2016
Primary completion
Dec 2017
Study completion Dec 2017
Sponsor
- Lead sponsor
- Phoenix Thera-lase Systems, LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 15, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 25 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Hypothesis: Use of high level vs low level cold laser treatments will reduce chronic pain and the need for PRN opioid-containing analgesic medications. Secondary Hypothesis: High level (vs low level) laser treatments will increase the patients level of physical activity and quality of sleep.
Conditions
- Pain
Interventions
Low level 1 WattDevice
The Phoenix Thera-Lase System will be on 1 watt
Phoenix Thera-Lase System 42Device
The Phoenix Thera-Lase System will be on 42 watts
Phoenix Thera-Lase System 74Device
The Phoenix Thera-Lase System will be on 74 watts
Primary outcomes
What the sponsor says the trial is designed to measure.
- Reduce chronic painTime frame: 1 month
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Phoenix Thera-Lase Systems
Dallas, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.